Skip to Main Content
Try STAT+ TODAY
Trending:
STAT+
Pharmalot
Biotech
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Webinar: Targeted cancer drugs: What’s on the market? What’s in the pipeline?

  • Damian Garde

By Damian Garde June 24, 2020

Reprints

Editor’s note: A recording of the webinar presentation is included below.

While immunotherapies get most of the headlines, targeted cancer treatments have revolutionized oncology in recent years, changing the lives of some patients by homing in on genetically defined tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Tags

In a massive victory for Democrats, Medicare is poised…
In a massive victory for Democrats, Medicare is poised to negotiate drug prices
Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and…
Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Why medical school should start at age 28
Why medical school should start at age 28
The Senate’s drug pricing bill is an inevitable solution.…
The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended…
Karuna Therapeutics’ schizophrenia drug achieves study goals, heralding new…
Karuna Therapeutics’ schizophrenia drug achieves study goals, heralding new treatment approach
Triple-negative breast cancer highlights the need to act against…
Triple-negative breast cancer highlights the need to act against health inequities

Recommended Stories